Department of Surgery, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, Osaka, 570-8507, Japan.
Surg Endosc. 2021 Apr;35(4):1572-1578. doi: 10.1007/s00464-020-07534-3. Epub 2020 Apr 3.
The laparoscopic magnified visual effects and evolution of the laparoscopic camera system have recently enabled us to observe details in the deep pelvic floor. Indications of laparoscopic surgery for colorectal cancer have been expanded, and laparoscopic (Lap) lateral pelvic node dissection (LLND) has been introduced in some institutions. We investigated the feasibility of Lap LLND in patients with locally advanced rectal cancer (LARC).
Lap LLND was performed in 38 patients diagnosed with cT3-4 or cN1-2 cancer during 2014-2018. We retrospectively analyzed their surgical and short-term outcomes.
Laparoscopic surgery was performed in all patients. cStages II/III/IV were found in 6/31/1 patients, respectively. Among them, 25 patients underwent neoadjuvant chemotherapy without radiotherapy. Lap unilateral LLND was performed in 6 patients and Lap bilateral LLND was performed 32 patients. The number of harvested lymph nodes (LNs) were 4 in the unilateral group and 15 in the bilateral group. Operation time was 531 min, and blood loss was 105 ml. Oral intake has started on postoperative day (POD) 3, and pelvic drain was removed on POD 7. Hospital stay was 18.5 days. Seven patients developed a neurogenic bladder (all Clavien-Dindo grade (CD) II and all occured in the bilateral LLND group), one patient developed abdominal bleeding (CD IIIb) and one patient developed anastomotic leakage (CD IIIb). Pathological results revealed 2/5/16/14/1 patients with pStages 0/I/II/III/IV, respectively. Four patients had histopathologically verified lateral pelvic lymph node metastases. There were no local recurrences after curative surgery (median follow-up 24.2 months).
Although the median follow-up period is relatively short and further follow-up is necessary, oncologically, especially in the point of local control rate, Lap LLND appears to have acceptable in the treatment of LARC without radiotherapy in experienced centers. Further investigations focusing on indications and the Lap LLND procedural technique are required.
腹腔镜放大的视觉效果和腹腔镜摄像系统的发展,使我们最近能够观察到深部盆底的细节。结直肠癌的腹腔镜手术适应证不断扩大,一些机构已经引入了腹腔镜(Lap)侧盆淋巴结清扫术(LLND)。我们研究了 Lap LLND 在局部进展期直肠癌(LARC)患者中的可行性。
2014 年至 2018 年期间,我们对 38 例诊断为 cT3-4 或 cN1-2 期癌症的患者进行了 Lap LLND。我们回顾性分析了他们的手术和短期结果。
所有患者均成功完成腹腔镜手术。c 期 II/III/IV 期患者分别为 6/31/1 例。其中 25 例患者未接受放疗的新辅助化疗。6 例患者行 Lap 单侧 LLND,32 例患者行 Lap 双侧 LLND。单侧组的淋巴结清扫数目为 4 枚,双侧组为 15 枚。手术时间为 531 分钟,出血量为 105 毫升。术后第 3 天开始口服,术后第 7 天拔除盆腔引流管。住院时间为 18.5 天。7 例患者发生神经性膀胱(均为 Clavien-Dindo 分级(CD)II 级,均发生在双侧 LLND 组),1 例患者发生腹腔出血(CD IIIb),1 例患者发生吻合口漏(CD IIIb)。病理结果显示,p 期 0/I/II/III/IV 患者分别为 2/5/16/14/1 例。4 例患者的侧盆淋巴结有组织病理学证实的转移。根治性手术后无局部复发(中位随访 24.2 个月)。
虽然中位随访时间相对较短,需要进一步随访,但在经验丰富的中心,对于未接受放疗的 LARC 患者,肿瘤学上,特别是局部控制率方面,Lap LLND 似乎是一种可行的治疗方法。需要进一步研究适应证和 Lap LLND 手术技术。